12 Oct '21
LUCIRA™ HEALTH COVID-19 Test Approved for Sale in Singapore
Singapore Health Sciences Authority issues approval by its Pandemic Special Access Route (PSAR) for the LUCIRA CHECK IT COVID-19 Test Kit. Lucira has partnered with Labgistics Asia Pte Ltd for the importation and distribution of its products in Singapore. EMERYVILLE, Calif., Oct.
08 Oct '21
LUCIRA™ HEALTH Provides Statement on Copan’s Recall of its FLOQSwabs
EMERYVILLE, Calif., Oct. 08, 2021 (GLOBE NEWSWIRE) -- Lucira Health, Inc. (“Lucira Health” or “Lucira”) (NASDAQ: LHDX), a medical technology company focused on the development and commercialization of transformative and innovative infectious disease test kits, today commented on the recent recall
20 Sep '21
LUCIRA™ HEALTH Hires Tony Allen as Chief Operations Officer
Veteran operations expert joins Lucira’s management team EMERYVILLE, Calif., Sept. 20, 2021 (GLOBE NEWSWIRE) -- Lucira Health, Inc. (“Lucira Health” or “Lucira”) (NASDAQ: LHDX), a medical technology company focused on the development and commercialization of transformative and innovative infectious
12 Aug '21
Lucira Health Announces Second Quarter 2021 Financial Results
EMERYVILLE, Calif., Aug. 12, 2021 (GLOBE NEWSWIRE) -- Lucira Health, Inc. (Nasdaq: LHDX) ("Lucira Health," "Lucira" or the "Company"), a medical technology company focused on the development and commercialization of transformative and innovative infectious disease test kits, today reported
29 Jul '21
Lucira Health to Announce Second Quarter 2021 Financial Results
EMERYVILLE, Calif., July 29, 2021 (GLOBE NEWSWIRE) -- Lucira Health, Inc. (“Lucira Health” or “Lucira”), a medical technology company focused on the development and commercialization of transformative and innovative infectious disease test kits, today announced that the company will report second
28 May '21
LUCIRA™ HEALTH Hires Chief Revenue Officer Kevin Collins
Appointment expands Lucira’s management team with medtech veteran EMERYVILLE, Calif. --(BUSINESS WIRE)--May 28, 2021-- Lucira Health, Inc. (Nasdaq: LHDX), a medical technology company focused on the development and commercialization of transformative and innovative infectious disease test kits,
13 May '21
Lucira Health Announces First Quarter 2021 Financial Results
EMERYVILLE, Calif, May 13, 2021 (GLOBE NEWSWIRE) -- Lucira Health, Inc. ("Lucira Health," "Lucira" or the "Company") (NASDAQ: LHDX), a medical technology company focused on the development and commercialization of transformative and innovative infectious disease test kits, today reported financial
12 May '21
LUCIRA™ CHECK IT COVID-19 Self-Test Now Available on Amazon
This FDA EUA first and only PCR quality, single-use, COVID-19 at home, self-test kit is available for $55 to all Amazon US customers EMERYVILLE, Calif. --(BUSINESS WIRE)--May 12, 2021-- Lucira Health, Inc. (Nasdaq: LHDX), a medical technology company focused on the development and commercialization
Displaying 1 - 10 of 20